Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry (2023)
https://pubmed.ncbi.nlm.nih.gov/36053919/

Back to the Future: Is the Schober Test Dispensable in Juvenile Spondyloarthritis? (2023)
https://pubmed.ncbi.nlm.nih.gov/36725058/

Improving the design of RCTs in non-radiographic axial spondyloarthritis. (2022)
https://pubmed.ncbi.nlm.nih.gov/35562426/

Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials (2022)
https://pubmed.ncbi.nlm.nih.gov/36335714/

Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood (2019)
https://pubmed.ncbi.nlm.nih.gov/31128893/

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31436036/

Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota (2018)
https://pubmed.ncbi.nlm.nih.gov/30029674/

Gastrointestinal and Hepatic Disease in Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29149924/